Clinical OMICs 22. Mai 2026 FDA Approves Datroway as First-Line Therapy for Triple-Negative Breast Cancer
FDA News Releases 22. Mai 2026 FDA Approves First Treatment for Chronic Hepatitis Delta Virus (HDV) Infection
Endpoints News 22. Mai 2026 AstraZeneca wins EU backing for breast cancer drug, splitting with FDA panel
Merck & Co. 22. Mai 2026 ASCO26: 5 data snapshots ahead of the year’s biggest cancer drug meeting - BioPharma Dive